AQP4 and myeloid sarcoma: In 2006, Wingerchuk and colleagues [58] proposed the diagnostic criteria for NMO that require ON, transverse myelitis (TM), and at least two of three supportive criteria: contiguous spinal cord MRI lesion extending over three or more segments, brain MRI non-diagnostic for MS, or AQP4-IgG seropositivity.